| related words |
| mg |
| krystexxa |
| pma |
| dacogen |
| ferumoxytol |
| increlex |
| pralatrexate |
| dose |
| erbitux |
| folotyn |
| veridex |
| pathway |
| vantas |
| qnexa |
| integrilin |
| costar |
| velcade |
| zfp |
| obesity |
| refusal |
|
| related documents |
| 1100962--3/1/2007--ENDO_PHARMACEUTICALS_HOLDINGS_INC |
| 887708--6/14/2006--CARACO_PHARMACEUTICAL_LABORATORIES_LTD |
| 1047699--3/3/2006--KING_PHARMACEUTICALS_INC |
| 1129425--3/6/2009--ZYMOGENETICS_INC |
| 1274057--2/28/2007--HOSPIRA_INC |
| 919722--3/16/2007--SUPERGEN_INC |
| 882095--2/27/2007--GILEAD_SCIENCES_INC |
| 1030339--3/16/2006--NANOGEN_INC |
| 918112--9/28/2010--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1023024--3/30/2010--BIOSANTE_PHARMACEUTICALS_INC |
| 918112--8/31/2009--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 887708--6/15/2009--CARACO_PHARMACEUTICAL_LABORATORIES_LTD |
| 887708--6/10/2008--CARACO_PHARMACEUTICAL_LABORATORIES_LTD |
| 1005201--3/16/2007--DEPOMED_INC |
| 919722--3/17/2008--SUPERGEN_INC |
| 1274057--2/28/2008--HOSPIRA_INC |
| 1115143--3/17/2008--ACUSPHERE_INC |
| 1000694--3/16/2007--NOVAVAX_INC |
| 887708--5/14/2007--CARACO_PHARMACEUTICAL_LABORATORIES_LTD |
| 1131517--3/30/2006--CORGENTECH_INC |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {loss, insurance, financial} |
| {debt, indebtedness, cash} |
| {control, financial, internal} |
| {operation, natural, condition} |
| {investment, property, distribution} |
| {personnel, key, retain} |
| {acquisition, growth, future} |
| {capital, credit, financial} |
| {provision, law, control} |
| {operation, international, foreign} |
| {interest, director, officer} |
| {cost, regulation, environmental} |
| {gas, price, oil} |
| {condition, economic, financial} |
| {stock, price, operating} |
| {customer, product, revenue} |
| {loan, real, estate} |
| {regulation, government, change} |
|